Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients

Mustafa Neamatallah, Mahmoud El-Bendary, Hatem Elalfy, Tarek Besheer, Mohamed Abd El-Maksoud, Dina Elhammady, Sally Abed, Mohamed Elegezy, Lamiaa Kandeel, Dalia Eldeib, Naser Mousa, Mohamed Abd El-Hafeez, Abdel-Hady El-Gilany, Gamal Esmat
  • Immunological Investigations, October 2019, Taylor & Francis
  • DOI: 10.1080/08820139.2019.1673772

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1080/08820139.2019.1673772

The following have contributed to this page: hatem elalfy, tarek besheer, Prof Nasser mousa, and Prof Abdel-Hady A El-Gilany